drug

lorundrostat

1 story · latest Aug 11, 2026

Status: Investigational

Relationships

Treats Hypertension

Developed by Mineralys Therapeutics

Timeline

Mineralys reports Q2 2026 results, names new CMO ahead of lorundrostat PDUFA date

Aug 11Quarterly updatelorundrostat Mineralys Therapeutics

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.